Skip to main content
. 2018 May 8;11(5):754. doi: 10.3390/ma11050754

Figure 4.

Figure 4

Recent examples of nanoparticle biotherapeutics and their targets in preventing atherosclerosis. Insights and techniques gained from siRNA studies has led to the delivery of larger and more complex molecules even up to cells.